Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib + Capecitabine + Irinotecan in Metastatic Colorectal Cancer
NCT00258232Phase 2Completed
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Start
- Jan 2002
- Primary completion
- Mar 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib in colorectal cancer (CRC), sponsored by Barbara Ann Karmanos Cancer Institute. Started Jan 2002; status: completed.
02
Drugs
celecoxib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00258232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00258232.